Who Paid My Doc
Jivi
Drug Hematology
NDC 0026-3942-25
General payments
$563,143
Research payments
$1,262,600
Through program year 2025, $563,143 in general payments and $1,262,600 in research payments were reported against Jivi (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $66,407 | 185 |
| 2025 | Research | $369,131 | 54 |
| 2024 | General | $51,287 | 135 |
| 2024 | Research | $203,218 | 77 |
| 2023 | General | $21,380 | 173 |
| 2023 | Research | $468,699 | 111 |
| 2022 | General | $171,805 | 316 |
| 2022 | Research | $71,166 | 10 |
| 2021 | General | $60,830 | 129 |
| 2021 | Research | $57,445 | 46 |
| 2020 | General | $46,805 | 59 |
| 2020 | Research | $61,567 | 22 |
| 2019 | General | $144,630 | 330 |
| 2019 | Research | $31,375 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,327 general · 324 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.